Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Convertible Debt: 2022-2024

Historic Convertible Debt for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $197.5 million.

  • Gossamer Bio's Convertible Debt rose 0.49% to $198.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.3 million, marking a year-over-year increase of 0.49%. This contributed to the annual value of $197.5 million for FY2024, which is 0.47% up from last year.
  • As of FY2024, Gossamer Bio's Convertible Debt stood at $197.5 million, which was up 0.47% from $196.6 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Convertible Debt registered a high of $197.5 million during FY2024, and its lowest value of $195.7 million during FY2022.
  • For the 3-year period, Gossamer Bio's Convertible Debt averaged around $196.6 million, with its median value being $196.6 million (2023).
  • Data for Gossamer Bio's Convertible Debt shows a peak YoY climbed of 0.47% (in 2024) over the last 5 years.
  • Over the past 3 years, Gossamer Bio's Convertible Debt (Yearly) stood at $195.7 million in 2022, then increased by 0.45% to $196.6 million in 2023, then rose by 0.47% to $197.5 million in 2024.